Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Index levels reveal trends and potential turns in markets. This quick overview shows what index level tells you and how to apply it to decisions.
23,042 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Oil markets surged as geopolitical tensions flared, with brent crude briefly topping the $119 mark. This article outl...
SpaceX IPO chatter has investors buzzing and critics worried. This piece breaks down why the hype could outpace reali...
Feeling overwhelmed by money talk? This expert guide lays out quick steps to create a budget that actually sticks. Fr...
Oil prices dropped after remarks that U.S.-Iran conversations were productive, signaling a possible diplomatic shift ...
In a surprise move, President Trump said he would not sign the housing bill until Congress passes a separate voter-id...
The U.S. retirement system gets c-plus in key metrics, prompting policymakers to push overdue reforms. This report ex...
As inflation erodes purchasing power, a decades-old rule could push a larger portion of retirement income into taxabl...
Value stocks are regaining ground in May as investors rotate from growth; the VLUE, AVUV, and VBR trio are delivering...
As AI reshapes markets and policy, this analysis draws lessons from America's founding framework to guide personal fi...
High-income investors face a tax cliff with JEPI: the 8% distribution yield is largely ordinary income, trimming real...
Bitcoin is staging a comeback as technical indicators flash bullish. Traders eye a potential move toward $65,000 in t...